Jafron Biomedical Co.,Ltd. (SHE:300529)
17.95
+0.22 (1.24%)
Apr 1, 2026, 3:04 PM CST
-31.23% (1Y)
| Market Cap | 13.73B -31.6% |
| Revenue (ttm) | 2.04B -22.6% |
| Net Income | 481.79M -40.1% |
| EPS | 0.63 -37.8% |
| Shares Out | 774.36M |
| PE Ratio | 28.17 |
| Forward PE | 25.06 |
| Dividend | 0.80 (4.49%) |
| Ex-Dividend Date | May 26, 2025 |
| Volume | 3,759,900 |
| Average Volume | 3,553,808 |
| Open | 17.36 |
| Previous Close | 17.73 |
| Day's Range | 17.36 - 18.01 |
| 52-Week Range | 17.30 - 26.99 |
| Beta | 0.43 |
| RSI | 37.89 |
| Earnings Date | Apr 28, 2026 |